福建傲农生物科技集团股份有限公司关于调整公司独立董事津贴的公告

Group 1 - The company announced an adjustment to the independent director's allowance, increasing the annual fixed allowance from 120,000 RMB (including tax) to 168,000 RMB (including tax), effective from January 1, 2025 [1][2][14] - This adjustment aims to enhance the diligence and responsibility of independent directors following the company's judicial reorganization, aligning with the company's long-term development needs [2][14] - The proposal for the adjustment was approved by the board of directors and will be submitted to the shareholders' meeting for final approval [2][15] Group 2 - The fourth board meeting of the company was held on September 29, 2025, with all nine directors present, and the meeting's procedures complied with relevant laws and regulations [5][6] - The board approved several proposals, including increasing expected daily related party transactions for 2025 with both controlling and other related parties, which will also be submitted to the shareholders' meeting for approval [6][10][35] - The company plans to hold the third extraordinary shareholders' meeting on October 15, 2025, to discuss the approved proposals [19][67]